Isoprenoids and protein prenylation: implications in the pathogenesis and therapeutic intervention of Alzheimer's disease.

Isoprenoids and protein prenylation: implications in the pathogenesis and therapeutic intervention of Alzheimer's disease.
复制标题

DOI:
10.1080/10409238.2018.1458070
复制
发表时间:
2018-06
影响因子:
6.5
通讯作者:
Li L
Li L
中科院分区:
生物学2区
文献类型:
--
作者:
Jeong A;Suazo KF;Wood WG;Distefano MD;Li L

文献摘要

参考文献

被引文献

相似文献

The mevalonate-isoprenoid-cholesterol biosynthesis pathway plays a key role in human health and disease. The importance of this pathway is underscored by the discovery that two major isoprenoids, farnesyl and geranylgeranyl pyrophosphate, are required to modify an array of proteins through a process known as protein prenylation, catalyzed by prenyltransferases. The lipophilic prenyl group facilitates the anchoring of proteins in cell membranes, mediating protein-protein interactions and signal transduction. Numerous essential intracellular proteins undergo prenylation, including most members of the small GTPase superfamily as well as heterotrimeric G proteins and nuclear lamins, and are involved in regulating a plethora of cellular processes and functions. Dysregulation of isoprenoids and protein prenylation is implicated in various disorders, including cardiovascular and cerebrovascular diseases, cancers, bone diseases, infectious diseases, progeria, and neurodegenerative diseases including Alzheimer’s disease. Therefore, isoprenoids and/or prenyltransferases have emerged as attractive targets for developing therapeutic agents. Here, we provide a general overview of isoprenoid synthesis, the process of protein prenylation and the complexity of prenylated proteins, and pharmacological agents that regulate isoprenoids and protein prenylation. Recent findings that connect isoprenoids/protein prenylation with Alzheimer’s disease are summarized and potential applications of new prenylomic technologies for uncovering the role of prenylated proteins in the pathogenesis of Alzheimer’s disease are discussed.
DOI: 10.1074/jbc.m114.557124
发表时间: 2014-12-26
期刊: The Journal of biological chemistry
影响因子: --
作者:
Bishop P;Rubin P;Thomson AR;Rocca D;Henley JM
通讯作者: Henley JM
DOI: 10.1038/82797
发表时间: 2000-12-01
期刊: NATURE IMMUNOLOGY
影响因子: 30.5
作者:
Arbibe, L;Mira, JP;Knaus, UG
通讯作者: Knaus, UG
DOI: 10.1073/pnas.0503689102
发表时间: 2005-09-20
影响因子: 11.1
作者:
Andersen, OM;Reiche, J;Willnow, TE
通讯作者: Willnow, TE
DOI: 10.1016/j.bmcl.2011.06.053
发表时间: 2011-09-15
影响因子: 2.7
作者:
Bergman, Joel A.;Hahne, Kalub;Gibbs, Richard A.
通讯作者: Gibbs, Richard A.
DOI: 10.1126/science.275.5307.1796
发表时间: 1997-03-21
期刊: SCIENCE
影响因子: 56.9
作者:
Boyartchuk, VL;Ashby, MN;Rine, J
通讯作者: Rine, J